Board and Management

OUR

BOARD OF DIRECTORS AND MANAGEMENT

Chairman

Alexander Fällström

Year of birth: 1990
Chairman of the board since 2023
Shareholding: 780 183 + 58,884,863 shares (via company), 0 warrants.

Independent of the Company's management, dependent on major owners.

Background
Alexander Fällström has a degree in economics from Harvard University and has a background in Private Equity and M&A with a focus on Industrials and Business Services. Also experience in asset management. Previous employment at Capillar Advisory in Stockholm, as well as Goldman Sachs & Jefferies in London.
Board member

Johan Gralén

Year of birth: 1964
Board member since 2024
Shareholding: 0 shares, and 0 warrants.

Independent of the Company's management, dependent on the Company's major owners.

Background

Johan Gralén holds a Master of Science in Engineering from Luleå University and further education in international marketing, management and corporate governance from IHM, EFL and Harvard Law School. Gralén has held several senior positions within the Trelleborg Group and DIAB, where he was Executive Vice President for Asia and Asia-Pacific and Executive Vice President of Global Sales.

Board member

Anders Wallseth

Year of birth: 1974
Board member since 2024
Shareholding: 0 shares, 0 warrants.

Independent of the Company's management, dependent on major owners.

Background

Anders Wallseth holds a executive MBA från Copenhagen Business School and a B.Sc. Sociology from Lund Universit. He has previously been Senior Director of International Sales at HemoCue, a company known for its medical diagnostic products. He has been with the Danaher Group since 2008 and joined Radiometer Medical. Anders Wallseth has held several senior roles, including General Manager of the company in the UK and Ireland.

CEO

Patrik Elfwing

Year of birth: 1965
CEO since 2025
Shareholding: 0, 0 warrants

Background

Patrik Elfwing brings over 20 years of experience in leading positions from various industries such as IT, Retail and, above all, many years of experience in the Life Science industry, e.g. from Astra Zeneca, Pfizer and Bristol Myers Squibb where he has, among other things, been head of Sweden. The focus has always been on sales, international business development, market and overall leadership. He also brings with him solid experience from private equity-owned growth companies as well as larger international groups. 


Patrik Elfwing has an Executive Master's degree from Lund University but also has a degree from GIH and IHM.